What does Pharmacie dejardin do?

Pharmacie dejardin is a pharmacy in Beauraing. Public Limited, started on 20 March 1992, 1 establishment.

What is the address of Pharmacie dejardin?

The registered office of Pharmacie dejardin is located at rue de Rochefort 122, 5570 Beauraing.

Is Pharmacie dejardin still active?

Yes. According to the CBE (30 October 2026) Pharmacie dejardin is active, legal situation “Normale toestand”, started on 20 March 1992.

Is Pharmacie dejardin registered on Peppol?

Yes, Pharmacie dejardin is registered on the Peppol network with ID 0208:0446901764.

What is the enterprise number of Pharmacie dejardin?

The enterprise number of Pharmacie dejardin is BE0446901764.

When was Pharmacie dejardin founded?

Pharmacie dejardin was founded on 20 March 1992.

Who are the directors of Pharmacie dejardin?

According to the 2025 annual accounts, the directors of Pharmacie dejardin are: Gui DEJARDIN, DEJARDIN INVETS SRL.

Is Pharmacie dejardin a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 March 1992; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Pharmacie dejardin make in 2025?

Pharmacie dejardin posted a profit after taxes of € 159,085 in financial year 2025.

What is the revenue of Pharmacie dejardin?

As a small company, Pharmacie dejardin is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 348,751.

Pharmacie dejardin (Public Limited) - Beauraing

Dossier Pharmacie dejardin, printed on 30 October 2026 from databakkes.be/en/0446901764/pharmacie-dejardin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie dejardin from Beauraing, company number BE0446901764, closed financial year 2025 with a result of € 159,085 after tax. For that financial year Pharmacie dejardin recorded a gross margin of € 348,751 and equity of € 556,154. Compared with financial year 2024, the result moved from € 21,113 to € 159,085. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 556,154

▲ 40% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 159,085

▲ € 137,972 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 159,981

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 494,154.

People and assets in 2025

Vehicles and equipment

€ 8,360

▼ 48% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 762,233

▼ 15% vs 2024

€ 122,604 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 332,411

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,021

▼ 60% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 186,925 Gross margin 2022: € 186,925 First fiscal year in the series	€ 284,233 Gross margin 2023: € 284,233 ▲ 52% vs 2022 (€ 186,925) Favourable step	€ 162,204 Gross margin 2024: € 162,204 ▼ 43% vs 2023 (€ 284,233) Unfavourable step	€ 348,751 Gross margin 2025: € 348,751 ▲ 115% vs 2024 (€ 162,204) Favourable step	▲ 115%
Profit after taxes	€ 75,379 Profit after taxes 2022: € 75,379 First fiscal year in the series	€ 128,900 Profit after taxes 2023: € 128,900 ▲ 71% vs 2022 (€ 75,379) Favourable step	€ 21,113 Profit after taxes 2024: € 21,113 ▼ 84% vs 2023 (€ 128,900) Unfavourable step	€ 159,085 Profit after taxes 2025: € 159,085 ▲ € 137,972 vs 2024 (€ 21,113) Favourable step	▲ € 137,972
Equity	€ 247,056 Equity 2022: € 247,056 First fiscal year in the series	€ 375,957 Equity 2023: € 375,957 ▲ 52% vs 2022 (€ 247,056) Favourable step	€ 397,069 Equity 2024: € 397,069 ▲ 6% vs 2023 (€ 375,957) Favourable step	€ 556,154 Equity 2025: € 556,154 ▲ 40% vs 2024 (€ 397,069) Favourable step	▲ 40%
Total debts	€ 1,534,147 Total debts 2022: € 1,534,147 First fiscal year in the series	€ 1,469,758 Total debts 2023: € 1,469,758 ▼ 4% vs 2022 (€ 1,534,147) Favourable step	€ 1,334,015 Total debts 2024: € 1,334,015 ▼ 9% vs 2023 (€ 1,469,758) Favourable step	€ 1,185,793 Total debts 2025: € 1,185,793 ▼ 11% vs 2024 (€ 1,334,015) Favourable step	▼ 11%
Cash	€ 199,517 Cash 2022: € 199,517 First fiscal year in the series	€ 182,343 Cash 2023: € 182,343 ▼ 9% vs 2022 (€ 199,517) Unfavourable step	€ 148,607 Cash 2024: € 148,607 ▼ 19% vs 2023 (€ 182,343) Unfavourable step	€ 159,981 Cash 2025: € 159,981 ▲ 8% vs 2024 (€ 148,607) Favourable step	▲ 8%
Land & buildings	€ 996,234 Land & buildings 2022: € 996,234 First fiscal year in the series	€ 957,701 Land & buildings 2023: € 957,701 ▼ 4% vs 2022 (€ 996,234) Unchanged	€ 938,801 Land & buildings 2024: € 938,801 ▼ 2% vs 2023 (€ 957,701) Unchanged	€ 882,760 Land & buildings 2025: € 882,760 ▼ 6% vs 2024 (€ 938,801) Unchanged	▼ 6%
Retained profit	€ 185,056 Retained profit 2022: € 185,056 First fiscal year in the series	€ 313,957 Retained profit 2023: € 313,957 ▲ 70% vs 2022 (€ 185,056) Favourable step	€ 335,069 Retained profit 2024: € 335,069 ▲ 7% vs 2023 (€ 313,957) Favourable step	€ 494,154 Retained profit 2025: € 494,154 ▲ 47% vs 2024 (€ 335,069) Favourable step	▲ 47%
Bank debt	€ 954,153 Bank debt 2022: € 954,153 First fiscal year in the series	€ 942,286 Bank debt 2023: € 942,286 ▼ 1% vs 2022 (€ 954,153) Favourable step	€ 894,389 Bank debt 2024: € 894,389 ▼ 5% vs 2023 (€ 942,286) Favourable step	€ 762,233 Bank debt 2025: € 762,233 ▼ 15% vs 2024 (€ 894,389) Favourable step	▼ 15%
Balance sheet total	€ 1,781,203 Balance sheet total 2022: € 1,781,203 First fiscal year in the series	€ 1,845,715 Balance sheet total 2023: € 1,845,715 ▲ 4% vs 2022 (€ 1,781,203) Unchanged	€ 1,731,084 Balance sheet total 2024: € 1,731,084 ▼ 6% vs 2023 (€ 1,845,715) Unchanged	€ 1,741,947 Balance sheet total 2025: € 1,741,947 ▲ 1% vs 2024 (€ 1,731,084) Unchanged	▲ 1%

Key figures of Pharmacie dejardin, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie dejardin?

What happened at Pharmacie dejardin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Gui DEJARDIN stepped down as director. NBB
2030 DEJARDIN INVETS SRL stepped down as director. NBB
Jul 8, 2026 New annual accounts for financial year 2025: profit of € 159,085 (▲ € 137,972 vs 2024). Source: NBB ↗
2025 Gui DEJARDIN became a director. NBB
2025 DEJARDIN INVETS SRL became a director. NBB
May 4, 1992 New establishment in Beauraing. KBO
Mar 20, 1992 Start of the company according to the CBE. KBO

In short

From € 75,379 profit in 2022 to € 159,085 profit in 2025.

Paid € 103,876 in corporate taxes since 2022.

Best year ever: 2025, with € 159,085 profit.

Original PDFs at the National Bank ↗

Management

DEJARDIN INVEST SRL 100%

The stake of DEJARDIN INVEST SRL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie dejardin

The shares are held by DEJARDIN INVEST SRL (100%).

Directors

According to the 2025 annual accounts

Gui DEJARDIN

Director

since 2025 · until 2030

DEJARDIN INVETS SRL

Managing director · represented by Pierre DEJARDIN

Also active at: PHARMACIE ELSEN, PHARMACIE SAINTE-ANNE

since 2025 · until 2030

Shareholders

DEJARDIN INVEST SRL

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

rue de Rochefort 122

5570 Beauraing

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

GE DEJARDIN

€ 732,155 gross margin · 2025

SAUSSURE PHARMA

€ 46,727 gross margin · 2025

DEJARDIN INVEST SRL same network

€ 282,993 gross margin · 2025

Unité TVA GROUPE DEJARDIN

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0446.901.764

VAT number

BE 0446.901.764

Registered office

rue de Rochefort 122, 5570 Beauraing

Names & denominations

Pharmacie dejardin

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 March 1992

Peppol

Active · Active since 30 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie dejardin

Financials

What happened to Pharmacie dejardin?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions